Capricorn Venture Partners announces SCG as limited partner in the Capricorn Sustainable Chemistry Fund

Bangkok, Thailand and Leuven, Belgium: 23 August 2018 - SCG Chemicals Co., Ltd, part of the Siam Cement Public Company Limited (SCG), one of the largest integrated petrochemical companies in Thailand and a key industry leader in Asia, which offers a full range of petrochemical products, has joined the Capricorn Sustainable Chemistry Fund (CSCF) as limited partner.

SCG has a strong commitment in creating sustainability along with innovations. SCG Chemicals has focused on developing innovation and advanced technology to create high value-added products (HVA), services and solutions.

Cholanat Yanaranop, President of Chemicals Business, SCG: "CSCF matches SCG's focus on innovation and circular economy. Investing in the CSCF will bring us further corporate venturing insights and both early and later stage potential co-investment opportunities in the sustainable chemicals field."

Jos Peeters, Chairman of the Executive Committee of Capricorn Venture Partners says, "We already have a financially very strong shareholder base from which we can leverage significant co-investment for the fund investments. With SCG we are not only strengthening the shareholder base of CSCF further, but we have also a partner on board that brings insights, innovation and access to new markets."

Jacques van Rijckevorsel, chairman of the CSCF: "As a former corporate executive I know what the added value of a fund investment can be for the innovation capability of a corporate investor. It does not only improve the reach of the innovation field, but it also broadens the view of the corporation beyond its current business areas. It provides a good view on technology and business possibilities that may arise beyond the horizon of the normal corporate business planning cycles and allow for early stage option development."

More info on the press release.


Next > Capricorn Venture Partners leads financing round at c-LEcta and lays foundation for further corporate growth

Previous > Mainstay Medical announces the appointment of Matthew Onaitis as Chief Financial Officer